Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations
Keywords: Atrial fibrillation; Antiarrhythmic drug; Sodium-channel blocker; Electrophysiology; Pharmacology; Trigerred activityAF, atrial fibrillation; AP, action potential; APA, action potential amplitude; APD85, action potential duration at 85% repolarization; BC